rs7073015

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001161352.2(KCNMA1):​c.*1957C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.786 in 865,032 control chromosomes in the GnomAD database, including 268,856 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.80 ( 48763 hom., cov: 28)
Exomes 𝑓: 0.78 ( 220093 hom. )

Consequence

KCNMA1
NM_001161352.2 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.449

Publications

9 publications found
Variant links:
Genes affected
KCNMA1 (HGNC:6284): (potassium calcium-activated channel subfamily M alpha 1) This gene encodes the alpha subunit of calcium-activated BK channel. The encoded protein is involved in several physiological processes including smooth muscle contraction, neurotransmitter release and neuronal excitability. Mutations in this gene are associated with a spectrum of neurological disorders including Paroxysmal Nonkinesigenic Dyskinesia 3, Idiopathic Generalized Epilepsy 16 and Liang-Wang syndrome. [provided by RefSeq, Aug 2022]
KCNMA1 Gene-Disease associations (from GenCC):
  • generalized epilepsy-paroxysmal dyskinesia syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • Liang-Wang syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • cerebellar atrophy, developmental delay, and seizures
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 10-76885309-G-A is Benign according to our data. Variant chr10-76885309-G-A is described in ClinVar as [Benign]. Clinvar id is 300927.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.898 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNMA1NM_001161352.2 linkc.*1957C>T 3_prime_UTR_variant Exon 28 of 28 ENST00000286628.14 NP_001154824.1 Q12791-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNMA1ENST00000286628.14 linkc.*1957C>T 3_prime_UTR_variant Exon 28 of 28 1 NM_001161352.2 ENSP00000286628.8 Q12791-1

Frequencies

GnomAD3 genomes
AF:
0.804
AC:
119662
AN:
148894
Hom.:
48735
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.905
Gnomad AMI
AF:
0.810
Gnomad AMR
AF:
0.707
Gnomad ASJ
AF:
0.761
Gnomad EAS
AF:
0.499
Gnomad SAS
AF:
0.613
Gnomad FIN
AF:
0.867
Gnomad MID
AF:
0.732
Gnomad NFE
AF:
0.795
Gnomad OTH
AF:
0.766
GnomAD4 exome
AF:
0.782
AC:
560354
AN:
716114
Hom.:
220093
Cov.:
9
AF XY:
0.783
AC XY:
261077
AN XY:
333562
show subpopulations
African (AFR)
AF:
0.914
AC:
12206
AN:
13354
American (AMR)
AF:
0.651
AC:
591
AN:
908
Ashkenazi Jewish (ASJ)
AF:
0.758
AC:
3394
AN:
4480
East Asian (EAS)
AF:
0.473
AC:
1566
AN:
3314
South Asian (SAS)
AF:
0.610
AC:
8666
AN:
14218
European-Finnish (FIN)
AF:
0.891
AC:
230
AN:
258
Middle Eastern (MID)
AF:
0.701
AC:
992
AN:
1416
European-Non Finnish (NFE)
AF:
0.787
AC:
514938
AN:
654694
Other (OTH)
AF:
0.757
AC:
17771
AN:
23472
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
5002
10005
15007
20010
25012
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16544
33088
49632
66176
82720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.804
AC:
119707
AN:
148918
Hom.:
48763
Cov.:
28
AF XY:
0.800
AC XY:
58051
AN XY:
72598
show subpopulations
African (AFR)
AF:
0.905
AC:
36972
AN:
40840
American (AMR)
AF:
0.706
AC:
10519
AN:
14892
Ashkenazi Jewish (ASJ)
AF:
0.761
AC:
2636
AN:
3464
East Asian (EAS)
AF:
0.499
AC:
2546
AN:
5106
South Asian (SAS)
AF:
0.613
AC:
2907
AN:
4744
European-Finnish (FIN)
AF:
0.867
AC:
7969
AN:
9196
Middle Eastern (MID)
AF:
0.754
AC:
214
AN:
284
European-Non Finnish (NFE)
AF:
0.795
AC:
53630
AN:
67426
Other (OTH)
AF:
0.767
AC:
1577
AN:
2056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1134
2267
3401
4534
5668
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
848
1696
2544
3392
4240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.788
Hom.:
28511
Bravo
AF:
0.795
Asia WGS
AF:
0.618
AC:
2142
AN:
3468

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Generalized epilepsy-paroxysmal dyskinesia syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
4.4
DANN
Benign
0.36
PhyloP100
0.45
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7073015; hg19: chr10-78645067; COSMIC: COSV54292767; COSMIC: COSV54292767; API